Suchergebnisse
Katalog
Mehr
Suchmaske
Suchergebnisse einschränken oder erweitern
Aktive Suchfilter
Weniger Treffer
Art der Quelle
Thema
- non-small cell lung cancer 36 Treffer
- immune checkpoint inhibitors 22 Treffer
- immunotherapy 18 Treffer
- overall survival 15 Treffer
- epidermal growth factor receptors 12 Treffer
-
45 weitere Werte:
- nsclc 12 Treffer
- chemotherapy 11 Treffer
- prognosis 11 Treffer
- cancer patients 10 Treffer
- lung cancer 8 Treffer
- programmed death-ligand 1 8 Treffer
- progression-free survival 7 Treffer
- immune checkpoint inhibitor 6 Treffer
- survival rate 6 Treffer
- anlotinib 5 Treffer
- drug side effects 5 Treffer
- targeted therapy 5 Treffer
- ipilimumab 4 Treffer
- non-small cell lung cancer (nsclc) 4 Treffer
- protein-tyrosine kinase inhibitors 4 Treffer
- radiotherapy 4 Treffer
- atezolizumab 3 Treffer
- biomarker 3 Treffer
- biomarkers 3 Treffer
- cancer 3 Treffer
- cancer chemotherapy 3 Treffer
- cancer treatment 3 Treffer
- chemoradiotherapy 3 Treffer
- efficacy 3 Treffer
- first-line 3 Treffer
- meta-analysis 3 Treffer
- pd-l1 3 Treffer
- pembrolizumab 3 Treffer
- pneumothorax 3 Treffer
- acquired drug resistance 2 Treffer
- antiangiogenic therapy 2 Treffer
- case report 2 Treffer
- cellular therapy 2 Treffer
- chinese people 2 Treffer
- circulating tumor dna 2 Treffer
- combination 2 Treffer
- combination drug therapy 2 Treffer
- docetaxel 2 Treffer
- hand-foot syndrome 2 Treffer
- immune checkpoint inhibitor (ici) 2 Treffer
- immune checkpoint proteins 2 Treffer
- immune-related adverse events 2 Treffer
- literature reviews 2 Treffer
- lobectomy (lung surgery) 2 Treffer
- lung diseases 2 Treffer
Publikation
Sprache
Geographischer Bezug
Inhaltsanbieter
74 Treffer
-
In: Frontiers in Oncology, 2024-02-20, S. 1-9Online academicJournalZugriff:
-
In: Frontiers in Oncology, 2024-02-12, S. 1-9Online academicJournalZugriff:
-
In: Frontiers in Oncology, 2023-09-19, S. 1-17Online academicJournalZugriff:
-
In: Frontiers in Endocrinology, 2023-12-28, S. 1-10Online academicJournalZugriff:
-
In: Frontiers in Oncology, 2024-06-04, S. 1-9Online academicJournalZugriff:
-
In: Frontiers in Oncology, 2024-05-27, S. 1-9Online academicJournalZugriff:
-
In: Frontiers in Oncology, 2023-09-25, S. 1-8Online academicJournalZugriff:
-
In: Frontiers in Oncology, Jg. 12 (2022-10-17), S. 1-11Online academicJournalZugriff:
-
In: Frontiers in Oncology, Jg. 12 (2022-09-07), S. 1-7Online academicJournalZugriff:
-
In: Frontiers in Oncology, Jg. 11 (2021-09-17), S. 1-16Online academicJournalZugriff:
-
In: Frontiers in Oncology, 2023-05-11, S. 1-16Online academicJournalZugriff:
-
In: Frontiers in Oncology, Jg. 11 (2021-03-10), S. N.PAG- (9S.)Online academicJournalZugriff:
-
In: Frontiers in Oncology, 2023-11-01, S. 1-7Online academicJournalZugriff:
-
In: Frontiers in Oncology, 2023-10-31, S. 1-12Online academicJournalZugriff:
-
In: Frontiers in Oncology, Jg. 11 (2021-10-11), S. 1-7Online academicJournalZugriff:
-
In: Frontiers in Oncology, 2023-09-19, S. 1-12Online academicJournalZugriff:
-
In: Frontiers in Pharmacology, Jg. 13 (2022-08-12), S. 1-12Online academicJournalZugriff:
-
In: Frontiers in Oncology, Jg. 12 (2022-07-28), S. 1-8Online academicJournalZugriff:
-
In: Frontiers in Oncology, 2024-05-28, S. 1-9Online academicJournalZugriff:
-
In: Frontiers in Oncology, Jg. 12 (2022-05-23), S. 1-10Online academicJournalZugriff: